| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |